These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28296569)

  • 21. Dying alone: the sad irrelevance of naloxone in the context of solitary opiate use.
    Wojcicki JM
    Addiction; 2019 Mar; 114(3):574-575. PubMed ID: 30461114
    [No Abstract]   [Full Text] [Related]  

  • 22. Development and process evaluation of an educational intervention for overdose prevention and naloxone distribution by general practice trainees.
    Klimas J; Egan M; Tobin H; Coleman N; Bury G
    BMC Med Educ; 2015 Nov; 15():206. PubMed ID: 26590066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naloxone (Narcan) nasal spray for opioid overdose.
    Med Lett Drugs Ther; 2016 Jan; 58(1485):1-2. PubMed ID: 26714239
    [No Abstract]   [Full Text] [Related]  

  • 24. Brief overdose education is sufficient for naloxone distribution to opioid users.
    Behar E; Santos GM; Wheeler E; Rowe C; Coffin PO
    Drug Alcohol Depend; 2015 Mar; 148():209-12. PubMed ID: 25595053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A scoping review of post opioid-overdose interventions.
    Bagley SM; Schoenberger SF; Waye KM; Walley AY
    Prev Med; 2019 Nov; 128():105813. PubMed ID: 31437462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Naloxone by Emergency Medical Services during Opioid Drug Overdose Resuscitation Efforts.
    Sumner SA; Mercado-Crespo MC; Spelke MB; Paulozzi L; Sugerman DE; Hillis SD; Stanley C
    Prehosp Emerg Care; 2016; 20(2):220-5. PubMed ID: 26383533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A True Antidote.
    Berlin J
    Tex Med; 2015 Oct; 111(10):41-7. PubMed ID: 26457843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revisiting Naloxone: A different take on overdose guidelines from Lee County, Fla.
    Hamel MG
    JEMS; 2016 Nov; 41(11):46-8. PubMed ID: 29188963
    [No Abstract]   [Full Text] [Related]  

  • 29. Virtue Ethics in a Value-driven World: It's Always with Me.
    Humbyrd CJ
    Clin Orthop Relat Res; 2020 Dec; 478(12):2714-2716. PubMed ID: 33009233
    [No Abstract]   [Full Text] [Related]  

  • 30. Differences in Naloxone Prescribing by Patient Age, Ethnicity, and Clinic Location Among Patients at High-Risk of Opioid Overdose.
    Kispert D; Carwile JL; Silvia KB; Eisenhardt EB; Thakarar K
    J Gen Intern Med; 2020 May; 35(5):1603-1605. PubMed ID: 31625039
    [No Abstract]   [Full Text] [Related]  

  • 31. Combative Treatment for Carfentanil Epidemic.
    Konapur R; Searls N; Babcock CCK; Blough E; Patel I
    J Addict Nurs; 2019; 30(1):2-3. PubMed ID: 30829994
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA Experience With Regulation of Naloxone Products to Address the Opioid Crisis and Opportunities for Leveraging Scientific Engagement.
    Amur S; Xu Y; Hertz S; Clingman C
    Clin Pharmacol Ther; 2021 Mar; 109(3):569-572. PubMed ID: 33241562
    [No Abstract]   [Full Text] [Related]  

  • 33. Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths.
    Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO
    J Urban Health; 2016 Feb; 93(1):117-30. PubMed ID: 26800987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naloxone Use in the School Setting--The Role of the School Nurse: Position Statement.
    King R; Embrey M
    NASN Sch Nurse; 2016 Mar; 31(2):119-20. PubMed ID: 26929212
    [No Abstract]   [Full Text] [Related]  

  • 35. Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists.
    Lim JK; Bratberg JP; Davis CS; Green TC; Walley AY
    J Addict Med; 2016; 10(5):300-8. PubMed ID: 27261669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV prevention and treatment strategies can help address the overdose crisis.
    Walley AY
    Prev Med; 2015 Nov; 80():37-40. PubMed ID: 25895840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Legal requirements and recommendations to prescribe naloxone.
    Haffajee RL; Cherney S; Smart R
    Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States.
    Green TC; Heimer R; Grau LE
    Addiction; 2008 Jun; 103(6):979-89. PubMed ID: 18422830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing opiate overdose deaths: examining objections to take-home naloxone.
    Bazazi AR; Zaller ND; Fu JJ; Rich JD
    J Health Care Poor Underserved; 2010 Nov; 21(4):1108-13. PubMed ID: 21099064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naloxone Effectiveness: A Systematic Review.
    Chimbar L; Moleta Y
    J Addict Nurs; 2018; 29(3):167-171. PubMed ID: 30180002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.